USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: AGENTA BIOTECHNOLOGIES, INC.
Address: Innovation Depot
1500 1st Ave. N.
BIRMINGHAM, AL 35203-
Located in HUBZone: No
Woman-Owned: No
Minority-Owned: No
URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $757,893.00 6
SBIR Phase II $1,971,170.00 2

Award List:

DEVELOPMENT OF AN HA2 DOMAIN BASED PERIODONTITIS VACCINE

Award Year / Program / Phase: 2001 / SBIR / Phase I
Agency: HHS
Principal Investigator: Arthur A. Decarlo
Award Amount: $113,397.00
Abstract:
DESCRIPTION: ( Applicant's Abstract) Periodontal disease can be diagnosed in >50 percent of adults and may contribute to poor health through oral and systemic infection. The disease process is induced by bacteria and the severity of the disease seems due in large part to the… More

Molecular Heparan Sulfate Delivery in Wound Regeneration

Award Year / Program / Phase: 2005 / SBIR / Phase I
Agency: HHS
Principal Investigator: Arthur A. Decarlo
Award Amount: $114,597.00
Abstract:
DESCRIPTION (provided by applicant): Tissue engineering, grafting procedures, regeneration, and tissue remodeling are developing therapies with great potential medical value. None of these therapeutic modalities are yet fully effective or predictable. Glycosaminoglycan-decorated proteoglycans such… More

Molecular Probes for Platelet Heparanase-Digested

Award Year / Program / Phase: 2006 / SBIR / Phase I
Agency: HHS
Principal Investigator: Arthur A. Decarlo
Award Amount: $121,980.00
Abstract:
DESCRIPTION (provided by applicant): The project proposed by Agenta Biotechnologies, Inc. will produce diagnostic molecular tools to identify where destructive changes in skin, kidney, heart, eyes, bones, and other organs have occurred. These molecular probes do not exist and would be useful in… More

Molecular Heparan Sulfate Delivery in Guided Tissue Regeneration

Award Year / Program / Phase: 2007 / SBIR / Phase I
Agency: HHS
Principal Investigator: Arthur A. Decarlo
Award Amount: $94,058.00
Abstract:
DESCRIPTION (provided by applicant): The role of proteoglycans and carbohydrate polymers such as heparan sulfate in biological processes are becoming better understood, but this new frontier has only begun to be explored. Tissue regeneration is also an eme rging frontier. This proposed research,… More

Molecular Delivery of Heparan Sulfate in Wound Regeneration

Award Year / Program / Phase: 2007 / SBIR / Phase II
Agency: HHS
Principal Investigator: Arthur A. Decarlo
Award Amount: $883,710.00
Abstract:
DESCRIPTION (provided by applicant): The role of proteoglycans and carbohydrate polymers such as heparan sulfate in biological processes are becoming better understood, but this new frontier has only begun to be explored. Tissue regeneration is also an eme rging frontier. This proposed research,… More

Molecular Heparan Sulfate Delivery in Guided Tissue Regeneration

Award Year / Program / Phase: 2009 / SBIR / Phase II
Agency: HHS
Principal Investigator: Arthur A. Decarlo
Award Amount: $1,087,460.00
Abstract:
DESCRIPTION (provided by applicant): Barrier membranes are an important adjunct to regeneration therapy aimed at restoring the form and function of the mouth. Commercially available barrier membranes are used in dental surgeries to help retain bone graftin g materials, to help exclude epithelium and… More

Nucleic acid delivery of growth factors and heparan sulfate proteoglycans for enh

Award Year / Program / Phase: 2010 / SBIR / Phase I
Agency: HHS
Principal Investigator: April L. Ellis
Award Amount: $156,792.00
Abstract:
DESCRIPTION (provided by applicant): In chronic wounds, numerous factors contribute to the diminished healing. Wound healing constituents, including heparan sulfate proteoglycans and numerous growth factors, are essential to normal skin wound healing. Seve ral key growth factors such as FGF, VEGF,… More

DNA Pro-Drug Technology in Localized Wound Healing and Tissue Regeneration

Award Year / Program / Phase: 2011 / SBIR / Phase I
Agency: HHS
Principal Investigator: Arthur A. Decarlo – 205-307-6500
Award Amount: $157,069.00
Abstract:
DESCRIPTION (provided by applicant): Advancement in wound management or tissue repair has been limited by the complexities, costs and limited efficacy of purified recombinant growth factors. Further, the combination of these recombinant proteins for moresophisticated approaches is complicated by… More